butalbital

Metabolite details

Identifier

UZVHFVZFNXBMQJ-UHFFFAOYSA-N

InChI Key

UZVHFVZFNXBMQJ-UHFFFAOYSA-N

IUPAC name

5-(2-methylpropyl)-5-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione

Preferred name

butalbital

INN name

butalbitalum

Synonym

5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione

ChEBI

CHEBI:102524

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
• Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• Male_19_days_vs_Male_1_day
• CIDP_patient_vs_healthy_control
• Control_vs_BP3_Low_Concentration